Alphatec Spine Names New Chief Financial Officer
16 Juni 2008 - 2:45PM
PR Newswire (US)
- Peter C. Wulff brings 25 years of financial and operational
management experience in medical device and life sciences
industries CARLSBAD, Calif., June 16 /PRNewswire/ -- Alphatec Spine
announced today that Peter C. Wulff, who has more than 25 years of
financial and operational management in the medical device and life
sciences industries, has been named the company's new Chief
Financial Officer, Vice President and Treasurer. (Logo:
http://www.newscom.com/cgi-bin/prnh/20080616/AQM017LOGO) Most
recently, Mr. Wulff served as Executive Vice President and Chief
Financial Officer for Artes Medical, Inc. (NASDAQ:ARTE), a San
Diego-based medical technology company. In that position, he
assisted the company in raising over $120 million in capital,
including successfully managing its initial public offering (IPO)
on NASDAQ. In addition, he established a responsive infrastructure
to support the company's commercial development and U.S. market
launch of its primary product. Prior to joining Artes Medical, Mr.
Wulff served in senior finance positions at both public and
privately-held medical device and pharmaceutical companies
including CryoCor, Inc., Natural Alternatives International, Inc.,
Epimmune Inc. and Ligand Pharmaceuticals Inc. While in these
positions, in the aggregate, he helped raise more than $250 million
in equity and debt financing, completed M&A transactions valued
at over $270 million, directed the launch of commercial operations
in Europe and orchestrated financial turnarounds and strategic
collaborations. "Peter Wulff will be a real asset for Alphatec,"
said Dirk Kuyper, the company's President and CEO. "He has an
extremely strong background in the medical device industry and has
built and directed operational infrastructure and financial
reporting systems for both U.S. and international businesses.
Peter's expertise will allow us to better manage our business as we
seek to continue our growth and expansion of our operations." Mr.
Wulff immigrated to the U.S. from The Netherlands and earned a B.A.
in both Economics and Germanic Languages and an M.B.A. in Finance
from Indiana University. He is also a Certified Management
Accountant. About Alphatec Spine Alphatec Spine, Inc. is a wholly
owned subsidiary of Alphatec Holdings, Inc. (NASDAQ:ATEC). Alphatec
Spine is a medical device company involved in the design,
development, manufacturing and marketing of products for the
surgical treatment of spine disorders, primarily focused on the
aging spine. The company's mission is to combine world-class
customer service with innovative, surgeon-driven design that will
help improve the aging patient's quality of life. The company is
poised to achieve its goal through new solutions for patients with
osteoporosis and other aging spine deformities, improved minimally
invasive products and techniques and integrated biologics
solutions. In addition to its U.S. operations, Alphatec Spine also
markets its spine products in Europe. In Asia, the company markets
a broad line of spine and orthopedic products through its
subsidiary, Alphatec Pacific, Inc. For more information, please
visit http://www.alphatecspine.com/. Forward Looking Statements
This press release may contain "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainty. Such statements are based on
management's current expectations and are subject to a number of
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
Alphatec cautions investors that there can be no assurance that
actual results or business conditions will not differ materially
from those projected or suggested in such forward-looking
statements as a result of various factors, including, but not
limited to the risks detailed from time to time in Alphatec's SEC
reports. Alphatec disclaims any intention or obligation to update
or revise any forward-looking statements, whether as a result of
new information, future events, or otherwise, unless required by
law. For more information: Ebun S. Garner Alphatec Spine, Inc.
760-494-6748
http://www.newscom.com/cgi-bin/prnh/20080616/AQM017LOGO
http://photoarchive.ap.org/ DATASOURCE: Alphatec Spine, Inc.
CONTACT: Ebun S. Garner of Alphatec Spine, Inc., +1-760-494-6748,
Web site: http://www.alphatecspine.com/
Copyright
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024